ACE inhibitor or Angiotensin Receptor Blocker (if intolerant of ACE inhibitor) in diabetes with evidence of renal disease i.e., dipstick proteinuria or microalbuminuria (>30 mg/24 h) with or without serum biochemical renal impairment. Here, ACE is linked to kidney disorder.